Title: Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor.
Journal: Scientific reports 20140101
Title: MicroRNA gene dosage alterations and drug response in lung cancer.
Journal: Journal of biomedicine & biotechnology 20110101
Title: Interaction between double helix DNA fragments and the new antitumor agent sabarubicin, Men10755.
Journal: Bioorganic & medicinal chemistry 20100215
Title: Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells.
Journal: Molecular cancer 20100101
Title: Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.
Journal: Cancer gene therapy 20090501
Title: In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
Journal: Biochemical pharmacology 20080915
Title: Ongoing phase I and II studies of novel anthracyclines.
Journal: Cardiovascular toxicology 20070101
Title: Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050215
Title: Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism.
Journal: Molecular pharmacology 20050101
Title: LC-MS-MS determination of nemorubicin (methoxymorpholinyldoxorubicin, PNU-152243A) and its 13-OH metabolite (PNU-155051A) in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis 20021015
Title: Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells.
Journal: FEBS letters 20010323
Title: Quintieri L, et al. Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes. Clin Cancer Res. 2005 Feb 15;11(4):1608-17.
Title: Quintieri L, et al. In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes. Biochem Pharmacol. 2008 Sep 15;76(6):784-95.
Title: Sabatino MA, et al. Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells. Mol Cancer. 2010 Sep 24;9:259.
Title: Lu H, et al. Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer. Cancer Gene Ther. 2009 May;16(5):393-404.
